Sunrakshakk Industries India Ltd (539300)
With reference to above subject please find attached herewith press release regarding financial result Q1 FY 27 of the company
Press Release - Q1FY27
- Revenue 276.33 Cr +120.64% y-y; EBITDA 22.59 Cr +94.41% y-y; PAT 15.04 Cr +130.67% y-y
- FMCG and FMCG Intermediates contributed ~90.6% of revenue, up from 83% in FY26
- New soap production line at Roorkee added ~1,700 MT monthly capacity; total FMCG capacity 20,840 MT/month
- EBITDA margin 8.18% (down from 10.19% in Q4FY26) due to higher raw material costs
- PAT margin improved to 5.44% from 5.21% in Q1FY26
- Company targets ~1000 Cr revenue by FY28 with focus on profitable growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 539300 — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add 539300 to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Sunrakshakk Industries India Ltd
Important.
The summary above is generated automatically from Sunrakshakk Industries India Ltd's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.